![]() PCOS prevalence is between 10 to 13% as demonstrated in the guideline process.1,2 PCOS aetiology is complex clinical presentation is heterogeneous with reproductive, metabolic, and psychological features.1,2 Women internationally experience delayed diagnosis and dissatisfaction with care.3-5 Clinical practice in the assessment and management of PCOS remains inconsistent, with ongoing key practice evidence gaps. Polycystic ovary syndrome (PCOS) is the most common endocrinopathy affecting reproductive-aged women, with impacts across the lifespan from adolescence to post menopause. With effective translation, the Guideline will address priorities identified by women with PCOS, upskill healthcare professionals, empower consumers, improve care and outcomes, identify key research gaps, and promote vital future research. Personal characteristics, preferences, culture and values are considered, in addition to resource availability across different settings. There is an emphasis on improved education and awareness of healthcare professionals, partnership in care, and empowerment of women with PCOS. ![]() The aim is to support women and their healthcare providers to optimize diagnosis, assessment and management of PCOS. The guideline and translation program were developed with full consumer participation at all stages including priority topics and outcomes for those with PCOS. ![]() Building on the 2018 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome (PCOS), this Guideline updates and expands clinical questions, aiming to ensure that women with PCOS receive optimal, evidence-based care that meets their needs and improves health outcomes.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |